1. Home
  2. STN vs BIO Comparison

STN vs BIO Comparison

Compare STN & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STN
  • BIO
  • Stock Information
  • Founded
  • STN 1954
  • BIO 1952
  • Country
  • STN Canada
  • BIO United States
  • Employees
  • STN N/A
  • BIO N/A
  • Industry
  • STN Military/Government/Technical
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • STN Consumer Discretionary
  • BIO Industrials
  • Exchange
  • STN Nasdaq
  • BIO Nasdaq
  • Market Cap
  • STN 12.0B
  • BIO 6.0B
  • IPO Year
  • STN N/A
  • BIO N/A
  • Fundamental
  • Price
  • STN $110.39
  • BIO $251.56
  • Analyst Decision
  • STN
  • BIO Strong Buy
  • Analyst Count
  • STN 0
  • BIO 4
  • Target Price
  • STN N/A
  • BIO $324.25
  • AVG Volume (30 Days)
  • STN 174.4K
  • BIO 407.6K
  • Earning Date
  • STN 08-06-2025
  • BIO 07-31-2025
  • Dividend Yield
  • STN 0.41%
  • BIO N/A
  • EPS Growth
  • STN 14.85
  • BIO N/A
  • EPS
  • STN 2.34
  • BIO N/A
  • Revenue
  • STN $4,208,787,002.00
  • BIO $2,541,100,000.00
  • Revenue This Year
  • STN $11.87
  • BIO N/A
  • Revenue Next Year
  • STN $7.82
  • BIO $3.49
  • P/E Ratio
  • STN $46.71
  • BIO N/A
  • Revenue Growth
  • STN 16.16
  • BIO N/A
  • 52 Week Low
  • STN $73.18
  • BIO $211.43
  • 52 Week High
  • STN $110.39
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • STN 70.67
  • BIO 65.86
  • Support Level
  • STN $107.28
  • BIO $237.42
  • Resistance Level
  • STN $110.17
  • BIO $254.82
  • Average True Range (ATR)
  • STN 1.45
  • BIO 7.14
  • MACD
  • STN -0.19
  • BIO 2.35
  • Stochastic Oscillator
  • STN 100.00
  • BIO 89.82

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: